Financial Perspectives’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $777K | Hold |
11,256
| – | – | 0.23% | 63 |
|
|
2025
Q1 | $782K | Hold |
11,256
| – | – | 0.27% | 58 |
|
|
2024
Q4 | $968K | Buy |
11,256
+61
| +0.5% | +$5.25K | 0.33% | 46 |
|
|
2024
Q3 | $1.33M | Sell |
11,195
-165
| -1% | -$19.6K | 0.46% | 39 |
|
|
2024
Q2 | $1.62M | Hold |
11,360
| – | – | 0.6% | 33 |
|
|
2024
Q1 | $1.46M | Buy |
11,360
+15
| +0.1% | +$1.93K | 0.55% | 36 |
|
|
2023
Q4 | $1.17M | Buy |
11,345
+34
| +0.3% | +$3.52K | 0.48% | 39 |
|
|
2023
Q3 | $1.03M | Buy |
11,311
+1
| +0% | +$91 | 0.47% | 40 |
|
|
2023
Q2 | $915K | Hold |
11,310
| – | – | 0.4% | 43 |
|
|
2023
Q1 | $900K | Hold |
11,310
| – | – | 0.43% | 40 |
|
|
2022
Q4 | $765K | Buy |
11,310
+74
| +0.7% | +$5.01K | 0.39% | 45 |
|
|
2022
Q3 | $560K | Hold |
11,236
| – | – | 0.31% | 51 |
|
|
2022
Q2 | $626K | Hold |
11,236
| – | – | 0.35% | 47 |
|
|
2022
Q1 | $624K | Buy |
11,236
+460
| +4% | +$25.5K | 0.29% | 52 |
|
|
2021
Q4 | $603K | Buy |
10,776
+2,898
| +37% | +$162K | 0.29% | 53 |
|
|
2021
Q3 | $378K | Sell |
7,878
-9,012
| -53% | -$433K | 0.19% | 73 |
|
|
2021
Q2 | $707K | Sell |
16,890
-1,121,868
| -99% | -$47M | 0.34% | 51 |
|
|
2021
Q1 | $8.45M | Buy |
1,138,758
+1,121,868
| +6,642% | +$8.32M | 0.42% | 38 |
|
|
2020
Q4 | $590K | Sell |
16,890
-100
| -0.6% | -$3.49K | 0.34% | 49 |
|
|
2020
Q3 | $590K | Buy |
16,990
+2
| +0% | +$69 | 0.39% | 40 |
|
|
2020
Q2 | $556K | Buy |
16,988
+4
| +0% | +$131 | 0.4% | 38 |
|
|
2020
Q1 | $511K | Hold |
16,984
| – | – | 0.41% | 33 |
|
|
2019
Q4 | $492K | Buy |
+16,984
| New | +$492K | 0.34% | 37 |
|